BACKGROUND:Individuals with anxiety disorders often do not receive an accurate diagnosis or adequate treatment in primary care. AIMS: To analyse the cost-effectiveness of an optimised care model for people with anxiety disorders in primary care. METHOD: In a cluster randomised controlled trial, 46 primary care practices with 389 individuals positively screened with anxiety were randomised to intervention (23 practices, 201 participants) or usual care (23 practices, 188 participants). Physicians in the intervention group received training on diagnosis and treatment of anxiety disorders combined with the offer of a psychiatric consultation-liaison service for 6 months. Anxiety, depression, quality of life, service utilisation and costs were assessed at baseline, 6-month and 9-month follow-up. RESULTS: No significant differences were observed between intervention and control group on the Beck Anxiety Inventory, Beck Depression Inventory and EQ-5D during follow-up. Total costs were higher in the intervention group (euro4911 v. euro3453, P = 0.09). The probability of an incremental cost-effectiveness ratio <euro50 000 per quality-adjusted life year was below 10%. CONCLUSIONS: The optimised care model did not prove to be cost-effective.
RCT Entities:
BACKGROUND: Individuals with anxiety disorders often do not receive an accurate diagnosis or adequate treatment in primary care. AIMS: To analyse the cost-effectiveness of an optimised care model for people with anxiety disorders in primary care. METHOD: In a cluster randomised controlled trial, 46 primary care practices with 389 individuals positively screened with anxiety were randomised to intervention (23 practices, 201 participants) or usual care (23 practices, 188 participants). Physicians in the intervention group received training on diagnosis and treatment of anxiety disorders combined with the offer of a psychiatric consultation-liaison service for 6 months. Anxiety, depression, quality of life, service utilisation and costs were assessed at baseline, 6-month and 9-month follow-up. RESULTS: No significant differences were observed between intervention and control group on the Beck Anxiety Inventory, Beck Depression Inventory and EQ-5D during follow-up. Total costs were higher in the intervention group (euro4911 v. euro3453, P = 0.09). The probability of an incremental cost-effectiveness ratio <euro50 000 per quality-adjusted life year was below 10%. CONCLUSIONS: The optimised care model did not prove to be cost-effective.
Authors: Jens-Oliver Bock; Dirk Heider; Herbert Matschinger; Hermann Brenner; Kai-Uwe Saum; Walter E Haefeli; Hans-Helmut König Journal: Eur J Health Econ Date: 2014-12-20
Authors: Jens-Oliver Bock; André Hajek; Hermann Brenner; Kai-Uwe Saum; Herbert Matschinger; Walter Emil Haefeli; Ben Schöttker; Renate Quinzler; Dirk Heider; Hans-Helmut König Journal: Health Serv Res Date: 2016-06-20 Impact factor: 3.402
Authors: Hans-Helmut König; Anja Born; Oliver Günther; Herbert Matschinger; Sven Heinrich; Steffi G Riedel-Heller; Matthias C Angermeyer; Christiane Roick Journal: Health Qual Life Outcomes Date: 2010-05-05 Impact factor: 3.186
Authors: Jens-Oliver Bock; Melanie Luppa; Christian Brettschneider; Steffi Riedel-Heller; Horst Bickel; Angela Fuchs; Jochen Gensichen; Wolfgang Maier; Karola Mergenthal; Ingmar Schäfer; Gerhard Schön; Siegfried Weyerer; Birgitt Wiese; Hendrik van den Bussche; Martin Scherer; Hans-Helmut König Journal: PLoS One Date: 2014-03-17 Impact factor: 3.240
Authors: Hans-Helmut König; Hanna Leicht; Horst Bickel; Angela Fuchs; Jochen Gensichen; Wolfgang Maier; Karola Mergenthal; Steffi Riedel-Heller; Ingmar Schäfer; Gerhard Schön; Siegfried Weyerer; Birgitt Wiese; Hendrik van den Bussche; Martin Scherer; Matthias Eckardt Journal: BMC Health Serv Res Date: 2013-06-15 Impact factor: 2.655
Authors: Enrique Alvarez; Jose L Carrasco; José M Olivares; Vanessa López-Gómez; Inma Vilardaga; María Perez Journal: Clin Pract Epidemiol Ment Health Date: 2012-11-16
Authors: Jochen Gensichen; Thomas S Hiller; Jörg Breitbart; Tobias Teismann; Christian Brettschneider; Ulrike Schumacher; Alexander Piwtorak; Hans-Helmut König; Heike Hoyer; Nico Schneider; Mercedes Schelle; Wolfgang Blank; Paul Thiel; Michel Wensing; Jürgen Margraf Journal: Trials Date: 2014-04-06 Impact factor: 2.279